BioSpace News Archive

Business

Metavention Closes $65M, Appoints New CEO

Berg most recently served as the CEO of Torax Medical, which was acquired by Ethicon, a division of Johnson & Johnson, in 2017.

January 8, 2018
·
4 min read
Silence Therapeutics: Post Year End Business Update

Silence Therapeutics announces a post year end update.

January 8, 2018
·
5 min read
Drug Development

Ascendis Pharma Provides Update on Rare Disease Endocrinology Pipeline and Presents Initial Phase I Data for TransCon PTH

The company is reviewing the status of, and milestones for, its three wholly-owned product candidates during a presentation today at the 36th Annual J.P. Morgan Healthcare Conference.

January 8, 2018
·
6 min read
Biotech Beach

Biosig Technologies Completes Private Placement - Jan. 8, 2018

The Company issued 3,008,607 common shares at a price of $1.50 per share and a half warrant with a 3-year expiration at a cash exercise price of $1.50.

January 8, 2018
·
3 min read
Cytovation Completes NOK 30m Financing Round to Progress Cypep-H1 Through Phase I/IIa Clinical Study in Cutaneous Warts

Cytovation announces it has raised NOK 10m in a private funding round, completing the second stage of fundraising, having raised NOK 20m in June 2017.

January 8, 2018
·
1 min read
Planmeca Emerald and Planmeca PlanScan Intraoral Scans Accepted by Clearcorrect

Planmeca is pleased to announce that the new Planmeca Emerald intraoral scanner is accepted for use with the ClearCorrect clear aligner system, joining the Planmeca PlanScan intraoral scanner.

January 8, 2018
·
2 min read
Business

Imcyse Announces a Research Collaboration With Pfizer in Rheumatoid Arthritis (RA)

Under the terms of the agreement, Pfizer will provide an undisclosed amount to fund the research activities, and Pfizer has an exclusive option to negotiate a license agreement for a limited period following the research activities.

January 8, 2018
·
2 min read
Business

IRIDEX Announces Preliminary Operational and Financial Results for 2017 Fourth Quarter and Full Year

Total revenue for the fourth quarter of 2017 expected to be $11.0 to $11.1 million.

January 8, 2018
·
2 min read
Biotech Bay

Spirosure Raising $15M Series C-2 Financing to Expand Commercialization of Fenom PRO

The funds being raised will be used for sales and regulatory activities in Europe, China and Japan where the company is recruiting teams to commercialize its product.

January 8, 2018
·
5 min read
Business

AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue

Fourth quarter revenue is expected to be at least $16.5 million, up 45% compared to the fourth quarter of 2016 revenue of $11.4 million.

January 8, 2018
·
5 min read